Keyphrases
Acute Kidney Injury
8%
Acute Respiratory Distress Syndrome
11%
Angiogenesis
7%
Antidepressants
12%
Astrocytes
13%
Biomaterials
7%
Bipolar Disorder
45%
Cardiovascular Disease
7%
Cell Therapy
12%
Cell-based
19%
Cell-derived
7%
Cell-free Fetal DNA
7%
Cell-mediated
7%
Central Nervous System
7%
Chile
62%
Chilean
35%
Chronic Dialysis
8%
Chronic Kidney Disease
11%
Chronic Stress
7%
Clinical Features
7%
Confidence Interval
16%
COVID-19
21%
During Pregnancy
13%
Endometrial Stem Cells
20%
Exosomes
42%
Experimental Autoimmune Encephalomyelitis
8%
Extracellular Vesicles
17%
Female Fertility
8%
Fetus
9%
First Trimester
13%
Fluoxetine
17%
Forebrain
7%
Gestational Age
8%
Gestational Diabetes Mellitus
11%
Hemodialysis
7%
Human Mesenchymal Stem Cells (hMSCs)
14%
Hypertension
9%
Hypoxia
8%
Immunization
13%
Inducible Nitric Oxide Synthase
13%
Infectious Diseases
12%
Inflammation
12%
Interleukin-17 (IL-17)
7%
Invasive Pneumococcal Disease
16%
Ischemia
7%
Ischemia Injury
10%
Ischemia-reperfusion Injury
14%
Kidney
10%
Latin America (LATAM)
10%
Macrophages
14%
Major Depressive Disorder
7%
Maternal Plasma
11%
Mesenchymal Stem Cells
100%
Mesenchymal Stromal Cells
23%
Meta-analysis
9%
MicroRNA
16%
Mitochondria
16%
Mitochondrial Transfer
7%
Myocardial Infarction
7%
N-methyl-D-aspartate Receptor (NMDAR)
8%
Neisseria Meningitidis
8%
Neural Stem Cells
8%
NF-B
7%
Nitric Oxide
7%
Noncardiac Surgery
10%
Obesity
9%
Odds Ratio
7%
PCV10
7%
Pharmacogenomics
7%
Placebo
9%
Placenta
9%
Postsynaptic Density Protein 95 (PSD-95)
22%
Preeclampsia
37%
Pregnancy Trimester
7%
Pregnant Women
18%
Quantitative PCR
12%
Randomized Clinical Trial
9%
Regulatory T (Treg) Cells
8%
Regulatory T Cells
7%
Reperfusion
8%
Rheumatoid Arthritis
11%
Risk Factors
7%
Santiago De Chile
11%
Selective Intrauterine Growth Restriction (sIUGR)
11%
Sepsis
7%
Small Extracellular Vesicles
21%
Spironolactone
8%
Stem Cell Therapy
7%
Stem Cell-derived
7%
Stem Cells
10%
Synaptic Plasticity
8%
Systemic Lupus Erythematosus
13%
T Cells
17%
T Helper 17 (Th17)
22%
Therapeutic Potential
7%
Therapeutic Properties
7%
Toll-like
8%
TrkB
8%
Tumor Necrosis Factor-α
7%
Vaccination
12%
Medicine and Dentistry
Acute Kidney Injury
9%
Acute Respiratory Distress Syndrome
8%
Adolescence
6%
Angiogenesis
5%
Apoplexy
7%
Biological Marker
9%
Bipolar Disorder
18%
Bleeding
6%
Cardiovascular Disease
7%
Cardiovascular System
6%
Case-Control Study
5%
Cell Therapy
10%
Cesarean Section
5%
Chronic Kidney Disease
6%
Cohort Analysis
10%
COVID-19
14%
Disease
37%
Exosome
12%
Female Fertility
8%
Fetus Growth
5%
Fibroblast Growth Factor 23
6%
First Trimester Pregnancy
17%
Gestational Age
10%
Gestational Diabetes
10%
Hemodialysis
6%
In Vitro
6%
Infection
17%
Intrauterine Growth Retardation
8%
Ischemia
9%
Lung
8%
Maternal Plasma
6%
Meningococcal Disease
14%
Mesenchymal Stem Cell
31%
Messenger RNA
8%
Meta-Analysis
9%
microRNA
7%
Mitochondrion
6%
Neonatal Infant
5%
Neutrophil Gelatinase Associated Lipocalin
5%
Noncardiac Surgery
8%
Osteoarthropathy
5%
Ovarian Cancer
6%
Oxidative Stress
5%
Pediatrics
9%
Peritoneal Dialysis
12%
Placebo
6%
Placenta
7%
Pneumococcus Vaccine
5%
Pre-Eclampsia
25%
Pregnancy
6%
Premature Labor
8%
Prevalence
9%
Public Health
9%
Randomized Clinical Trial
7%
Randomized Controlled Trial
5%
Reperfusion Injury
6%
Serotype
16%
Stem Cell
19%
Stromal Cell
6%
Systemic Lupus Erythematosus
10%
Trophoblast
6%
Uterine Artery
5%